High-Risk Genotypes of Human Papillomavirus at Diverse Anogenital Sites among Chinese Women: Infection Features and Potential Correlation with Cervical Intraepithelial Neoplasia

Chao Zhao,Jiahui An,Mingzhu Li,Jingran Li,Yun Zhao,Jianliu Wang,Heidi Qunhui Xie,Lihui Wei
DOI: https://doi.org/10.3390/cancers16112107
2024-06-01
Cancers
Abstract:Background: Both cervical cancer and cervical intraepithelial neoplasia (CIN) are associated with human papillomavirus (HPV) infection at different anogenital sites, but the infection features of high-risk (HR) HPVs at these sites and their association with cervical lesions have not been well characterized. Given the limitation of cervical HPV 16/18 test in screening patients with high-grade CIN (CIN 2+), studies on whether non-16/18 HR-HPV subtype(s) have potential as additional indicator(s) to improve CIN 2+ screening are needed. Methods: The infection of 15 HR-HPVs in vulva, anus, vagina, and cervix of 499 Chinese women was analyzed, and CIN lesion-associated HR-HPV subtypes were revealed. Results: In addition to the well-known cervical-cancer-associated HPV 16, 52, and 58, HPV 51, 53, and 56 were also identified as high-frequency detected subtypes prevalently and consistently present at the anogenital sites studied, preferentially in multi-infection patterns. HPV 16, 52, 58, 56, and 53 were the top five prevalent subtypes in patients with CIN 2+. In addition, we found that cervical HPV 33/35/52/53/56/58 co-testing with HPV 16/18 might improve CIN 2+ screening performance. Conclusion: This study provided a new insight into HR-HPV screening strategy based on different subtype combinations, which might be used in risk stratification clinically.
oncology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is the limitations of the current routine cervical high - risk human papillomavirus (HR - HPV) 16/18 detection methods for screening high - grade squamous intraepithelial lesions of the cervix (CIN 2+). Specifically, although cervical cancer and its precursor lesion, cervical intraepithelial neoplasia (CIN), are related to HPV infections in different genital sites, the characteristics of high - risk HPV infections in these sites and their associations with cervical lesions have not been fully characterized. In addition, the existing cervical HR - HPV 16/18 tests are not sufficiently effective in screening patients with CIN 2+. To improve this situation, the researchers analyzed the infection characteristics of 15 high - risk HPV types in four genital sites (vulva, anus, vagina, and cervix) among Chinese women and evaluated the potential links between these infections and cervical lesions. The research results show that, in addition to the known cervical - cancer - related subtypes such as HPV 16, 52, and 58, the infection rates of HPV 51, 53, and 56 in the vulva, anus, vagina, and cervix are also high, and there is a certain consistency of infection among these sites. In addition, the study also found that, in addition to cervical HPV 16/18, cervical HPV 33/35/52/53/56/58 may serve as potential indicators, which are helpful to improve the accuracy of predicting CIN 2+. In conclusion, this study provides new insights into an HR - HPV screening strategy based on different type combinations, which may be used for clinical risk stratification. By identifying and understanding the distribution of different HR - HPV subtypes in different anatomical sites and their relationships with cervical lesions, the study aims to provide more effective tools for the early detection and prevention of cervical cancer and its precursor lesions.